Gout, urate-lowering drugs, and risk of cardiovascular disease: can we clinically trust in the adjusted real-life data?

Eur Heart J. 2021 Nov 21;42(44):4589-4591. doi: 10.1093/eurheartj/ehab667.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Cardiovascular Diseases*
  • Gout* / drug therapy
  • Humans
  • Pharmaceutical Preparations*
  • Trust
  • Uric Acid

Substances

  • Pharmaceutical Preparations
  • Uric Acid